Vimarsana
Biggest News Aggregation in the World

Page 14 - Trial Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Data Today - Breaking & Trending Today

KGO ABC World News Tonight With David Muir February 13, 2022 00:11:00 - Vimarsana News

KGO ABC World News Tonight With David Muir February 13, 2022 00:11:00

Youngest children grappling with the news that vaccines for children 6 months to under 5 have been put on hold. pfizer, waiting for more trial data, delaying its request for fda authorization of its vaccine for that age group for a few more months. >> i think the more vaccines, for me, the better. but. >> reporter: but to wait a few months -- >> if it's for safety, i think it's a really good thing. >> reporter: pediatricians, including those at golden gate pediatrics outside san francisco, now telling parents to be patient. >> they understand but, you know, i think there's a bit of a letdown. ...

KGO ABC World News Tonight With David Muir February 1, 2022 23:33:00 - Vimarsana News

KGO ABC World News Tonight With David Muir February 1, 2022 23:33:00

For a low dose to be administered in two shots. the company expecting three doses will be needed but they submitted this new data for the two shots because of, quote, an urgent public health need, they said. the concern for children remains very high and tonight, we're inside this hospital in texas. 10 to 15 of the expected mothers who have come in to deliver are testing positive. the new moms now quarantines for their newborns to protect them. but first tonight, how soon could the fda decide on this request from pfizer for the youngest of children? abc's mireya villarreal leading us off from ...

CNN CNN Newsroom With Ana Cabrera January 31, 2022 18:44:00 - Vimarsana News

CNN CNN Newsroom With Ana Cabrera January 31, 2022 18:44:00

Full approval for people 18 and older. but there's still no vaccine approved or even authorized for kids under 5. pfizer's vaccine is the closest, yet a critical question remains, two doses or three? former fda leader dr. scott gottlieb says that is what is holding up emergency use authorization here. trial data shows the two-dose regimen for this age group has been less protective at protecting infection. but gottlieb argues that's not the point. the goal is to prevent serious or severe illness and two doses gives a child under 5 baseline immunity. let's get some perspective from an expert no...

KPIX CBS Evening News With Norah ODonnell February 14, 2022 23:37:00 - Vimarsana News

KPIX CBS Evening News With Norah ODonnell February 14, 2022 23:37:00

Surpassed cancer tco thesecond n the u.s. >> reporter: tonight as cases continue to drop from the omicron surge the american academy of meerkts reports the number of new covid cases among children is down nearly 53% from last week. >> the number of cases in kids is clearly dropping quickly, just as it is in adults. once again, pediatric cases mirror overall cases among the population. >> reporter: the a.e.p. also recorded nearly 300,000 child covid cases in the last week, as parents of children under five learn they must wait even longer for them to be vaccinated. on friday pfizer said it need...

MSNBC Hallie Jackson Reports March 18, 2022 19:33:00 - Vimarsana News

MSNBC Hallie Jackson Reports March 18, 2022 19:33:00

Dose for all adults. it's a lot broader than what pfizer had asked for. targeting only older people over 65. right now fourth doses are only available to folks who have weakened immune systems. i want to bring in on this our doctor, an msnbc medical contributor and former white house policy director for the obama administration. we're always glad to have you on the show. good afternoon. >> good afternoon, hallie. >> how significant is it that moderna wants this fourth dose given the green light for all adults? what does that say to you? what is the time line? >> yeah. it's interesting timing g...